InnAccel Technologies Pvt Ltd., an ambitious startup based in India, is making waves in the medical device industry by addressing critical healthcare challenges in emerging markets.
Since its inception in 2012, InnAccel has evolved from a medical technology accelerator to a pioneering developer of advanced medical devices, focusing on improving patient care in Critical Care and Maternal & Child Health.
Addressing Critical Healthcare Needs
InnAccel’s journey began with a mission to tackle the gaps in medical technology access, particularly in India and other emerging markets.
Utilizing the renowned Stanford Biodesign method, InnAccel identifies and validates pressing clinical needs through extensive clinical immersion.
This rigorous approach has led to the creation of a range of innovative products designed to meet specific healthcare challenges.
One of their standout innovations, VAPCARE, addresses the critical issue of Ventilator-Associated Pneumonia (VAP), a leading cause of ICU mortality.
VAPCARE is the world’s first automated system for managing oral hygiene and secretion in ventilated patients.
By ensuring compliance with infection prevention protocols, VAPCARE helps reduce the risk of lung infections and enhances ICU efficiency.
Another groundbreaking product is FETAL LITE, an AI-powered fetal heart rate monitor that uses fetal ECG technology.
This device is designed to improve fetal monitoring accuracy and accessibility, thereby reducing intrapartum deaths in low-resource settings.
Unlike traditional Doppler-based devices, FETAL LITE requires minimal operator training and provides reliable, real-time data.
Empowering Neonatal Care
In the realm of neonatal care, SAANS is a game-changer.
This portable, non-invasive breathing support device addresses the critical need for neonatal CPAP therapy across various healthcare settings, including transport.
With over 1,000 units deployed and more than 20,000 neonates treated in India, SAANS is making a significant impact on reducing neonatal mortality rates.
Focus on Accessibility
InnAccel’s dedication to making healthcare more accessible and affordable is reflected in innovative products such as EUSTACARE and NOXENO.
EUSTACARE offers an easy-to-use, cost-effective solution for Eustachian Tuboplasty, a minimally invasive procedure for Chronic Eustachian Tube Dysfunction.
NOXENO simplifies the removal of nasal foreign bodies in children, a common issue in India, with a design that ensures safe and effective use even by less experienced practitioners.
A Journey of Growth and Collaboration
InnAccel’s shift from supporting startups to developing its own product portfolio demonstrates a strong focus on innovation and impact.
In 2019, the company merged with Coeo Labs and Sattva Medtech, bringing together expertise and expanding its range of healthcare solutions.
InnAccel’s broad network of partners, including hospitals, academic institutions, and engineering firms, reflects its collaborative approach to addressing healthcare needs.
With a focus on using patented technologies to improve access, InnAccel aims to contribute to medical technology advancements in emerging markets and beyond.
Looking Ahead
As the medical device market continues to grow, InnAccel Technologies is poised to play a crucial role in addressing the unique healthcare needs of emerging markets.
With a robust portfolio of innovative solutions and a dedication to improving patient outcomes, InnAccel is set to continue its journey of transforming healthcare and saving lives.
